References
- Dobrivojević M, Špiranec K, Sinđić A. Involvement of bradykinin in brain edema development after ischemic stroke. Pflugers Arch. 2015;467 (2):201–12. doi:https://doi.org/10.1007/s00424-014-1519-x
- Wicka W, Küker W. Brain edema in neurooncology: radiological assessment and management. Onkologie. 2004;27:261–6.
- van Nieuwenhuizen D, Slot KM, Klein M, Verbaan D, Aliaga ES, Heimans JJ, Vandertop WP, Peerdeman SM, Reijneveld JC. The association between preoperative edema and postoperative cognitive functioning and health-related quality of life in WHO grade I meningioma patients. Acta Neurochir (Wien). 2019;161(3):579–88. doi:https://doi.org/10.1007/s00701-019-03819-2
- Kaal ECA, Vecht CJ. The management of brain edema in brain tumors. Curr Opin Oncol. 2004;16(6):593–600. doi:https://doi.org/10.1097/01.cco.0000142076.52721.b3
- Xu F-F, Sun S, Ho ASW, Lee D, Kiang KMY, Zhang X-Q, Wang AM, Wu EX, Lui W-M, Liu B-Y, et al. Effects of progesterone vs. dexamethasone on brain oedema and inflammatory responses following experimental brain resection. Brain Inj. 2014; 28 (12):1594–601. doi:https://doi.org/10.3109/02699052.2014.943289
- Won S, Sayeed I, Peterson BL, Wali B, Kahn JS, Stein DG. Vitamin D prevents hypoxia/reoxygenation-induced blood-brain barrier disruption via vitamin D receptor-mediated NF-kB signaling pathways. PLoS One. 2015; 10(3):e0122821. doi:https://doi.org/10.1371/journal.pone.0122821
- Hajimohammadebrahim-Ketabforoush M, Vahdat Shariatpanahi Z, Shahmohammadi M. In vitro and in vivo antitumor activity of vitamin D3 in malignant gliomas: a systematic review. Int J Cancer Manag. 2020;13(2):e94542. doi:https://doi.org/10.5812/ijcm.94542
- Evans MA, Kim HA, Ling YH, Uong S, Vinh A, De Silva TM, Arumugam TV, Clarkson AN, Zosky GR, Drummond GR, et al. Vitamin D3 supplementation reduces subsequent brain injury and inflammation associated with ischemic stroke. Neuromol Med. 2018;20(1):147–59. doi:https://doi.org/10.1007/s12017-018-8484-z
- Atif F, Sayeed I, Ishrat T, Stein DG. Progesterone with vitamin D affords better neuroprotection against excitotoxicity in cultured cortical neurons than progesterone alone. Mol Med. 2009;15(9–10):328–36. doi:https://doi.org/10.2119/molmed.2009.00016
- Cui C, Song S, Cui J, Feng Y, Gao J, Jiang P. Vitamin D receptor activation influences NADPH oxidase (NOX2) activity and protects against neurological deficits and apoptosis in a rat model of traumatic brain injury. Oxid Med Cell Longev. 2017; 2017:9245702. doi:https://doi.org/10.1155/2017/9245702
- Cekic M, Sayeed I, Stein DG. Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease. Front Neuroendocrinol. 2009; 30(2):158–72. doi:https://doi.org/10.1016/j.yfrne.2009.04.002
- Aminmansour B, Nikbakht H, Ghorbani A, Rezvani M, Rahmani P, Torkashvand M, Nourian M, Moradi M. Comparison of the administration of progesterone versus progesterone and vitamin D in improvement of outcomes in patients with traumatic brain injury: a randomized clinical trial with placebo group. Adv Biomed Res. 2012; 1:58. doi:https://doi.org/10.4103/2277-9175.100176
- Cekic M, Stein DG. Traumatic brain injury and aging: is a combination of progesterone and vitamin D hormone a simple solution to a complex problem? Neurotherapeutics. 2010;7(1):81–90. doi:https://doi.org/10.1016/j.nurt.2009.10.017
- Enkhjargal B, McBride DW, Manaenko A, Reis C, Sakai Y, Tang J, Zhang JH. Intranasal administration of vitamin D attenuates blood-brain barrier disruption through endogenous upregulation of osteopontin and activation of CD44/P-gp glycosylation signaling after subarachnoid hemorrhage in rats. J Cereb Blood Flow Metab. 2017; 37(7):2555–66. doi:https://doi.org/10.1177/0271678X16671147
- Sayeed I, Turan N, Stein DG, Wali B. Vitamin D deficiency increases blood-brain barrier dysfunction after ischemic stroke in male rats. Exp Neurol. 2019; 312:63–71. doi:https://doi.org/10.1016/j.expneurol.2018.11.005
- Guo T, Wang Y, Guo Y, Wu S, Chen W, Liu N. 1, 25-D3 protects from cerebral ischemia by maintaining BBB permeability via PPAR-γ activation. Front Cell Neurosci. 2018; 12:480.
- Guo X, Yuan J, Wang J, Cui C, Jiang P. Calcitriol alleviates global cerebral ischemia-induced cognitive impairment by reducing apoptosis regulated by VDR/ERK signaling pathway in rat hippocampus. Brain Res. 2019; 1724:146430. doi:https://doi.org/10.1016/j.brainres.2019.146430
- Velimirović M, Jevtić Dožudić G, Selaković V, Stojković T, Puškaš N, Zaletel I, Živković M, Dragutinović V, Nikolić T, Jelenković A, et al. Effects of vitamin D3 on the NADPH oxidase and matrix metalloproteinase 9 in an animal model of global cerebral ischemia. Oxid Med Cell Longev. 2018; 2018:3273654. doi:https://doi.org/10.1155/2018/3273654
- Yoshioka H, Hama S, Taniguchi E, Sugiyama K, Arita K, Kurisu K. Peritumoral brain edema associated with meningioma influence of vascular endothelial growth factor expression and vascular blood supply. Cancer. 1999; 85 (4):936–44. doi:https://doi.org/10.1002/(SICI)1097-0142(19990215)85:4<936::AID-CNCR23>3.0.CO;2-J
- Ha Paek S, Kim C-Y, Kim YY, Park IA, Kim MS, Kim DG, Jung H-W. Correlation of clinical and biological parameters with peritumoral edema in meningioma. J Neurooncol. 2002; 60 (3):235–45. doi:https://doi.org/10.1023/A:1021186401522
- Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumors of the central nervous system. 2nd ed. Berlin: Springer; 1993.
- Hou J, Kshettry VR, Selman WR, Bambakidis NC. Peritumoral brain edema in intracranial meningiomas: the emergence of vascular endothelial growth factor-directed therapy. Neurosurg Focus. 2013; 35 (6):E2. doi:https://doi.org/10.3171/2013.8.FOCUS13301
- Ide M, Jimbo M, Yamamoto M, Umebara Y, Hagiwara S, Kubo O. MIB-1 staining index and peritumoral brain edema of meningiomas. Cancer. 1996; 78 (1):133–43. doi:https://doi.org/10.1002/(SICI)1097-0142(19960701)78:1<133::AID-CNCR19>3.0.CO;2-0
- Simis A, de Aguiar PHP, Leite CC, Santana PA, Jr Rosemberg S, Teixeira MJ. Peritumoral brain edema in benign meningiomas: correlation with clinical, radiologic, and surgical factors and possible role on recurrence. Surg Neurol. 2008;70(5):471–7. doi:https://doi.org/10.1016/j.surneu.2008.03.006
- Merrill MJ, Oldfield EH. A reassessment of vascular endothelial growth factor in central nervous system pathology. J Neurosurg. 2005;103(5):853–68. doi:https://doi.org/10.3171/jns.2005.103.5.0853
- Wolburg-Buchholz K, Mack AF, Steiner E, Pfeiffer F, Engelhardt B, Wolburg H. Loss of astrocyte polarity marks blood-brain barrier impairment during experimental autoimmune encephalomyelitis. Acta Neuropathol. 2009;118(2):219–33. doi:https://doi.org/10.1007/s00401-009-0558-4
- Guo Q, Sayeed I, Baronne LM, Hoffman SW, Guennoun R, Stein DG. Progesterone administration modulates AQP4 expression and edema after traumatic brain injury in male rats. Exp Neurol. 2006;198 (2):469–78. doi:https://doi.org/10.1016/j.expneurol.2005.12.013
- Yuan J, Guo X, Liu Z, Zhao X, Feng Y, Song S, Cui C, Jiang P. Vitamin D receptor activation influences the ERK pathway and protects against neurological deficits and neuronal death. Int J Mol Med. 2018; 41(1):364–72. doi:https://doi.org/10.3892/ijmm.2017.3249
- Takahashi S, Maeda T, Sano Y, Nishihara H, Takeshita Y, Shimizu F, Kanda T. Active form of vitamin D directly protects the blood–brain barrier in multiple sclerosis. Clin Exp Neuroimmunol. 2017;8(3):244–54. doi:https://doi.org/10.1111/cen3.12398
- Shimizu F, Nishihara H, Kanda T. Blood-brain barrier dysfunction in immuno-mediated neurological diseases. Immunol Med. 2018; 41 (3):120–8. doi:https://doi.org/10.1080/25785826.2018.1531190
- Reszec J, Hermanowicz A, Rutkowski R, Turek G, Mariak Z, Chyczewski L. Expression of MMP-9 and VEGF in meningiomas and their correlation with peritumoral brain edema. Biomed Res Int. 2015; 2015:646853. doi:https://doi.org/10.1155/2015/646853
- Valable S, Montaner J, Bellail A, Berezowski V, Brillault J, Cecchelli R, Divoux D, Mackenzie ET, Bernaudin M, Roussel S, et al. VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by Ang-1. J Cereb Blood Flow Metab. 2005;25(11):1491–504. doi:https://doi.org/10.1038/sj.jcbfm.9600148
- Moukayed M, Grant WB. Molecular link between vitamin D and cancer prevention. Nutrients. 2013;5(10):3993–4021. doi:https://doi.org/10.3390/nu5103993
- Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005;57(2):173–85. doi:https://doi.org/10.1124/pr.57.2.4
- Go KG. The normal and pathological physiology of brain water. Adv Tech Stand Neurosurg. 1997;23:47–142. doi:https://doi.org/10.1007/978-3-7091-6549-2_2
- Dietrich JB. Endothelial cells of the blood-brain barrier: a target for glucocorticoids and estrogens? Front Biosci. 2004;9:684–93. doi:https://doi.org/10.2741/1272